Get started

Buy-sell

SNAP Upside PotentialIf you haven`t bought SNAP before the previous earnings: SNAP Key Fundamental Strengths in Q1 2025: Metric Q1 2025 Result Year-over-Year Change Revenue $1.36 billion +14% Daily Active Users (DAU) 460 million +9% Monthly Active Users (MAU) 900 million+ Net Loss $140 million -54% (improved) Adjusted EBITDA $108 million +137% Operating Cash Flow $152 million +72% Free Cash Flow $114 million +202% SNAP strong fundamental performance in Q1 2025, marked by accelerating revenue growth, expanding user engagement, sharply improving profitability, and robust cash flow generation, sets a solid foundation for a potential stock rally this year. The company’s innovation in AR, diversified revenue streams, and healthy balance sheet further support a bullish outlook. Investors focusing on fundamentals can view Snap as a growth stock with improving financial health and significant upside potential in 2025. My price target is $14. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:SNAPLong
by TopgOptions
Bullish Thesis: Why Oscar Health OSCR Could Rally Strong in 2025Oscar Health, OSCR, a technology-driven health insurance company, is positioned for a significant stock price appreciation in 2025. Despite some mixed short-term sentiment, the long-term outlook and recent analyst forecasts suggest a potential rally that could more than double the current share price. Here’s why OSCR could be a compelling bullish opportunity this year: 1. Strong Analyst Price Targets Indicate Upside of Over 125% According to recent forecasts, OSCR is expected to reach an average price of $31.40 in 2025, with some analysts projecting highs as much as $41.31—a potential upside exceeding 125% from the current price near $13.95. Monthly forecasts show a steady upward trajectory, with July 2025 targets around $37.24 and December 2025 targets near $34.67, highlighting sustained bullish momentum throughout the year. The average 12-month price target is around $34.40, representing a 146% upside, signaling strong confidence in OSCR’s growth prospects. 2. Innovative Business Model and Growth Potential Oscar Health leverages technology and data analytics to offer user-friendly, transparent health insurance plans, differentiating itself in a traditionally complex industry. Its focus on member engagement, telemedicine, and cost-effective care management positions it well to capture market share as healthcare consumers increasingly demand digital-first solutions. The company’s expanding footprint in both individual and Medicare Advantage markets provides multiple growth avenues. 3. Long-Term Vision and Market Opportunity Beyond 2025, forecasts remain highly bullish, with OSCR projected to reach $53.77 by 2027 and nearly $100 by 2030, reflecting strong secular growth potential in the health insurance and digital health sectors. Analysts see Oscar as a disruptive force with the potential to reshape healthcare delivery, driving substantial long-term shareholder value. 4. Improving Financial Metrics and Operational Execution Oscar has been improving its loss ratios and operating efficiencies, which are critical for sustainable profitability. The company’s investments in technology infrastructure and data-driven care management are expected to translate into better margins and revenue growth over time. 5. Market Sentiment and Analyst Ratings While some platforms show mixed short-term sentiment, the dominant analyst consensus is a "Buy" or "Moderate Buy," supported by strong price targets and growth forecasts. The stock’s current undervaluation relative to its growth potential creates a favorable risk-reward profile for investors.
NYSE:OSCRLong
by TopgOptions
AAOI Applied Optoelectronics potential rally by EOYApplied Optoelectronics AAOI is well-positioned for a strong rally toward $24 per share by the end of 2025, supported by multiple operational and strategic catalysts. A key recent development—the warrant agreement with Amazon—adds a powerful endorsement and financial backing that enhances the bullish case. 1. Amazon’s Strategic Warrant Agreement: A Major Vote of Confidence On March 13, 2025, AAOI issued a warrant to Amazon.com NV Investment Holdings LLC, granting Amazon the right to purchase up to approximately 7.95 million shares at an exercise price of $23.70 per share. About 1.3 million shares vested immediately, with the remainder vesting based on Amazon’s discretionary purchases, potentially up to $4 billion in total purchases over time. This agreement signals Amazon’s strong confidence in AAOI’s technology and its critical role as a supplier of high-speed optical transceivers for Amazon Web Services and AI data center infrastructure. The warrant price near $24 effectively sets a floor and a valuation benchmark, supporting the thesis that AAOI’s stock could reach or exceed this level by year-end. 2. Major Data Center Wins and Hyperscale Customer Re-Engagement AAOI recently resumed shipments to a major hyperscale customer, with volume shipments of high-speed data center transceivers expected to ramp significantly in the second half of 2025. This re-engagement with a key customer aligns with the surging demand for AI-driven data center infrastructure, providing a strong revenue growth catalyst. 3. Robust Revenue Growth and Margin Expansion Q1 2025 revenue doubled year-over-year to nearly $100 million, with gross margins expanding to over 30%, reflecting operational efficiencies and favorable product mix. The company expects to sustain strong quarterly revenue ($100–$110 million) and ramp production capacity to over 100,000 units of 800G transceivers per month by year-end, with 40% manufactured in the U.S. 4. Manufacturing Expansion and Supply Chain Resilience AAOI is scaling manufacturing in the U.S. and Taiwan, enhancing supply chain robustness and positioning itself to benefit from potential government incentives for domestic production. Its automated, largely in-house manufacturing capabilities provide a competitive edge in meeting hyperscale and AI data center demand. In conclusion: Amazon’s warrant agreement at a $23.70 strike price not only provides a direct valuation anchor near $24 but also serves as a powerful strategic endorsement of AAOI’s technology and growth prospects. Combined with robust revenue growth, expanding manufacturing capacity, and key customer re-engagement, AAOI has a compelling case to reach or exceed $24 per share by the end of 2025.
NASDAQ:AAOILong
by TopgOptions
Why Recursion Pharmaceuticals RXRX Could Be the NVDA of BiotechRecursion Pharmaceuticals RXRX is rapidly emerging as a transformative force in drug discovery, leveraging cutting-edge artificial intelligence and automation to industrialize and accelerate the development of new medicines. Here’s why RXRX could be the next NVIDIA (NVDA) of biotechnology and why its stock could soar by year-end: 1. AI-Powered Drug Discovery Platform with Unmatched Scale Recursion integrates AI, machine learning, automation, and advanced data science to decode biology and chemistry, dramatically reducing the time and cost of drug discovery. The company’s proprietary BioHive-2 supercomputer, built with NVIDIA’s DGX H100 systems, is the most powerful AI computing system wholly owned by any biopharma company, enabling Recursion to process biological data at unprecedented speeds. By reducing the number of compounds needed for clinical candidates from thousands to just 136–200 and shrinking development timelines to under a year, RXRX is fundamentally changing the economics of pharmaceutical R&D. 2. Strategic Partnerships and Industry Validation RXRX has forged high-profile partnerships with pharmaceutical giants such as Bayer, Roche/Genentech, Takeda, and Sanofi, validating its platform and unlocking milestone payments that could exceed $20 billion over time. The company’s collaboration with AI biotech Exscientia in a $700 million deal further cements its leadership in the AI-driven drug discovery space, creating a pipeline of 10 clinical and preclinical programs with hundreds of millions in potential milestones. NVIDIA itself holds over 7.7 million shares of RXRX, making it one of NVIDIA’s largest biotech investments and a strong endorsement of Recursion’s technology and long-term vision. 3. Explosive Revenue Growth and Strong Cash Position Analysts forecast Recursion’s revenue to grow at a 65% CAGR from $58.8 million in 2024 to $263 million by 2027, far outpacing the broader biotech sector. The company ended 2024 with over $600 million in cash, providing a solid runway for continued investment in R&D, platform expansion, and clinical trials. Wall Street analysts expect more than 50% upside in RXRX stock over the next 12–24 months, with multiple clinical milestones and partnership announcements as near-term catalysts. 4. Disruptive Vision: The “Virtual Cell” and Beyond RXRX is building toward a “virtual cell,” where AI models can simulate biological processes with such accuracy that wet lab experiments shift from data generation to validating computational predictions. This approach could dramatically improve drug development success rates, addressing the industry’s notorious 95% failure rate and positioning Recursion as the go-to platform for next-generation drug discovery. 5. Market Sentiment and Institutional Support RXRX has caught the attention of growth investors and major funds, including Cathie Wood’s ARK Invest, further boosting its profile and liquidity. Recent stock surges and high trading volumes reflect growing investor confidence in Recursion’s disruptive potential and the broader AI-in-biotech trend.
NASDAQ:RXRXLong
by TopgOptions
12
Bullish Thesis for INTC Intel Stock in 2025If you haven`t bought INTC before the previous earnings: Now Intel INTC is positioned for a potential turnaround and upside by the end of 2025, driven by strategic leadership changes, foundry business expansion, AI innovation, and favorable geopolitical dynamics. Here’s why INTC could head higher this year: 1. Leadership Transformation and Strategic Vision The appointment of Lip-Bu Tan as CEO in March 2025 has injected new optimism into Intel’s prospects. Tan is a respected semiconductor industry veteran, and his arrival was met with a 10% jump in INTC’s share price, reflecting renewed investor confidence in the company’s direction. 2. Foundry Business Expansion and Government Support Intel’s pivot toward a foundry-centric model is gaining momentum. The company is leveraging its U.S.-based manufacturing footprint to attract domestic and international clients, especially as geopolitical tensions and trade restrictions make U.S. chip production more attractive. There is speculation about strategic partnerships, such as TSMC potentially acquiring a stake in Intel’s foundry operations, which could accelerate technology transfers and client wins. The U.S. government is likely to continue supporting domestic semiconductor manufacturing through incentives and tariffs, directly benefiting Intel’s foundry ambitions. 3. AI and Next-Gen Product Launches Intel is aggressively targeting the AI and data center markets. The upcoming Jaguar Shores and Panther Lake CPUs, built on the advanced 18A process node, are set for release in the second half of 2025. These chips will be available not only for Intel’s own products but also for external clients like Amazon and Microsoft, expanding the addressable market. Intel’s renewed focus on AI accelerators and competitive cost structures could help it regain share in high-growth segments. 4. Financial Resilience and Market Position Despite recent setbacks, Intel remains a dominant player in the PC CPU market and continues to generate substantial revenue, outpacing some key competitors in the latest quarter. Analysts have revised their short-term price targets upward, with some projecting INTC could reach as high as $62—a potential upside of over 170% from current levels. Forecasts for 2025 suggest an average price target in the $40–$45 range, with bullish scenarios pointing even higher if execution on foundry and AI strategies meets expectations. 5. Technical and Sentiment Factors While technical analysis currently signals caution, the $18.50–$20 zone has provided strong support, and any positive news on foundry contracts or AI wins could catalyze a breakout from current consolidation patterns. Market sentiment has shifted more positively following the CEO change and strategic announcements, suggesting the potential for a sustained rebound if Intel delivers on its promises. In conclusion: Intel’s combination of visionary leadership, foundry expansion, AI innovation, and favorable geopolitical trends sets the stage for a potential stock price recovery by the end of 2025. With analyst targets and investor sentiment turning more bullish, INTC presents a compelling case for upside as it executes its turnaround strategy Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:INTCLong
by TopgOptions
Prostarm Microfinance Ltd: Investment Update Buy, Sell, OR Hold Technical Outlook: Prostar Microfinance Ltd. Current Market Structure: Prostar Microfinance Ltd. is presently consolidating within a narrow trading range between ₹112 and ₹118. This range-bound movement indicates indecision in the market, with neither bulls nor bears taking full control at this stage. Scenario-Based Strategic Guidance 1. Existing Shareholders (Including IPO Allottees): Investors already holding shares—especially those allotted during the IPO—are advised to continue holding their positions while the stock remains above the key support level of ₹112. However, if the stock breaches this level on a daily close basis and sustains below ₹112 on the following trading session, it would signal a breakdown of the current support zone. In such a case, we recommend exiting the position and waiting for technical stabilization or a new bullish setup. 2. Prospective Buyers (No Current Holdings): Investors looking to enter fresh positions should adopt a wait-and-watch approach until a clear breakout above ₹118 is observed. A breakout accompanied by significant volume and a confirmed close above ₹118 could offer a potential buying opportunity, with a near-term price target of ₹126. 3. Risk Monitoring: A sustained move below ₹112 could open the downside toward the ₹105–₹100 levels. Hence, strict stop-loss discipline is crucial, especially for short-term traders and technical participants. Summary : | Scenario Action Plan -------------------------- -------------------------------------------------- | Holding from IPO Hold above ₹112; exit if closes below and sustains | No Holdings Buy only after a breakout and close above ₹118 | Post-Breakout First Target ₹126 Disclaimer: This is a technical outlook and should not be construed as investment advice. Investors are advised to consider their risk appetite, broader market conditions, and consult financial advisors before making investment decisions.
NSE:PROSTARM
by Kartik_Elkunchwar
TSLA SellOff ! Elon Musk vs Donald Trump ! Beginning of the End?If you haven`t bought the dip on TSLA: Now you need to know that TSLA Tesla experienced a significant drop of 14% today, marking its worst single-day performance in over four years. This decline erased approximately $150 billion in market capitalization, bringing the stock down to $284.70. The immediate cause of this downturn is the escalating feud between CEO Elon Musk and President Donald Trump. Musk's public criticism of Trump's tax legislation, labeling it a "repugnant abomination," prompted Trump to threaten the revocation of government contracts with Musk's companies. This political clash has introduced significant uncertainty regarding Tesla's future government support. Beyond the political arena, Tesla's core business metrics are showing signs of strain. The company reported a 9% decline in quarterly revenues and a staggering 71% drop in profits. Additionally, Tesla has lost its leadership position in the electric vehicle market to China's BYD, indicating increased competitive pressure. cincodias.elpais.com Investor sentiment is also waning. A Morgan Stanley survey revealed that 85% of investors believe Musk's political activities are negatively impacting Tesla's business fundamentals. This perception is further exacerbated by declining sales in key markets, such as a 17% drop in Model Y registrations in California. thestreet.com Elon Musk and Donald Trump have publicly clashed, escalating a feud that has unraveled their once-close relationship. The dispute centers on several issues: Republican Tax and Immigration Bill: Musk criticized a sweeping Republican domestic policy bill backed by Trump, calling it a "disgusting abomination" on X. Trump claimed Musk initially had no issue with the bill, accusing him of being upset over the removal of an electric vehicle tax credit. Epstein Files Allegation: Musk alleged Trump's name appears in classified Jeffrey Epstein files, escalating tensions. Trump has not directly addressed this claim but responded by threatening to cut government contracts with Musk's companies. Personal and Financial Accusations: Musk argued Trump would have lost the 2024 election without his financial support, accusing him of ingratitude. Trump countered, saying he was "disappointed" in Musk, claiming he asked Musk to leave the administration and accused him of "Trump Derangement Syndrome." Government Contracts and Tariffs: Trump threatened to cancel "billions and billions" in government contracts with Musk's companies, like SpaceX, amid the feud. Separately, Musk reportedly made personal appeals to Trump on auto tariffs, which Trump noted might involve a conflict of interest. Cabinet Clash: Reports indicate Musk clashed with Trump’s cabinet, including Marco Rubio, over spending cuts related to the Department of Government Efficiency (DOGE), with some describing Musk's behavior as disruptive. Given these challenges, a price target of $215 for TSLA appears justified. The combination of political entanglements, deteriorating financial performance, and eroding investor confidence suggests that Tesla's stock may face continued downward pressure in the near term. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:TSLAShort
by TopgOptions
MRK Merck On the Verge of a Breakout? Unusual Calls !!Merck (MRK) is setting up for what could be a high-probability breakout. The stock has been in a falling wedge pattern for several months — a classic technical formation that often precedes sharp upside moves. Price action has now compressed to the end of the wedge, and we may be on the brink of a bullish resolution. 🔍 Technical Setup Falling Wedge Pattern nearing completion Price currently hovering near long-term support ($78.25) Strong bullish divergence forming on momentum indicators (RSI/MACD) The falling wedge is typically a reversal pattern, and given how deep MRK has pulled back from its highs ($134+), the risk/reward here looks compelling. 🔥 Options Flow Today’s options market added fuel to the fire: 48,000 call contracts traded expiring this Friday This sudden surge in short-dated call buying signals aggressive positioning for an imminent move This kind of volume is not retail-driven — it points to potential institutional interest 💡 The Bullish Case With the technical breakout structure in place and strong confirmation from options flow, the case for a bullish reversal is growing. If MRK can close above wedge resistance with volume, it opens the door to a quick move toward $85+, possibly even higher in the coming weeks. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:MRKLong
by TopgOptions
DOCU DocuSign Options Ahead of EarningsIf you haven`t bought DOCU before the previous earnings: Now analyzing the options chain and the chart patterns of DOCU DocuSign prior to the earnings report this week, I would consider purchasing the 93usd strike price Calls with an expiration date of 2025-6-6, for a premium of approximately $4.80. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:DOCULong
by TopgOptions
AVGO Broadcom Options Ahead of EarningsIf you haven`t bought AVGO before the rally: Now analyzing the options chain and the chart patterns of AVGO Broadcom prior to the earnings report this week, I would consider purchasing the 250usd strike price Calls with an expiration date of 2025-6-13, for a premium of approximately $14.75. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:AVGOLong
by TopgOptions
MOONPIG Is Taking Off — Thanks to James Wynn’s Viral CloutThe James Wynn Phenomenon: James Wynn, a crypto trader who turned $4 million into $100 million before losing nearly all of it in leveraged Bitcoin futures, has become a polarizing figure in the crypto space. His massive trades, including a $1.2 billion Bitcoin long position that ended in a $17.5 million loss and a subsequent $1 billion short position with 40x leverage, have made him a viral sensation. Despite these setbacks, Wynn’s resilience and bold moves keep him in the spotlight, with thousands of traders and investors following his every step. Wynn’s fame stems not just from his trading but from his ability to move markets. His posts on X, where he boasts a significant following, often trigger rapid price movements in the assets he mentions. This influence is now centered on $MOONPIG, a Solana-based meme coin that’s gaining traction thanks to his vocal support. $MOONPIG: A Meme Coin with Momentum: $MOONPIG, a meme coin built on the Solana blockchain, has seen its price surge by as much as 80% following Wynn’s endorsements, though it’s also faced volatility with a 30% drop in 24 hours and a 60% decline from its all-time high. Despite these fluctuations, the coin’s community-driven narrative and Wynn’s backing make it a compelling speculative play. Wynn’s posts on X reveal his belief in $MOONPIG’s potential to be the “next SafeMoon” of this cycle, predicting a run to a billion-dollar market cap. He’s emphasized its appeal to retail investors, calling it “normie-friendly” and highlighting its strong community as a key driver. This narrative aligns with the meme coin mania that often propels tokens like CRYPTOCAP:DOGE or CRYPTOCAP:SHIB to explosive gains during bullish market phases. Why I’m Bullish: Wynn’s Influence as a Catalyst: Wynn’s fame amplifies $MOONPIG’s visibility. His posts on X, such as one claiming he transferred profits to the $MOONPIG reserves wallet, signal commitment and attract attention. When Wynn speaks, traders listen, and his endorsements have already driven significant price action, with one instance sparking an 80% surge. Community Strength: Wynn has emphasized $MOONPIG’s community-driven ethos, stating it “doesn’t need KOLs or BS” and thrives on organic support. In the meme coin space, strong communities can sustain momentum, as seen with tokens like CRYPTOCAP:PEPE , which Wynn also supports. Market Timing: With Bitcoin hitting new highs and retail interest flooding back into crypto, $MOONPIG is well-positioned to ride the wave. Wynn’s thesis that retail investors will soon pour into altcoins aligns with current market sentiment, making $MOONPIG a potential beneficiary. Speculative Upside: Meme coins thrive on hype, and $MOONPIG’s low market cap relative to its potential—analysts like @KookCapitalLLC speculate a $1 billion valuation—offers significant upside for early investors. Even after recent pullbacks, the coin’s volatility suggests opportunities for traders who can stomach the risk.
Long
by TopgOptions
13
GameStop (GME) Is the New MSTR — And It Might Moon Harder ! If you haven`t bought the dip on GME: Now You need to know that GameStop (GME) is the new MSTR MicroStrategy — But With Meme Power! GME GameStop just made its boldest move yet: the company revealed it has purchased 4,710 Bitcoin, officially entering the crypto game in a serious way. While it hasn’t disclosed the total price paid, the intent is loud and clear — GameStop is transforming into a Bitcoin-holding company, just like MicroStrategy (MSTR) did back in 2020. This isn’t just about hype. In March, GameStop raised $1.3 billion through a convertible note offering, specifically to help fund Bitcoin purchases. It also updated its investment policy to formally add Bitcoin as a reserve asset — the same exact strategy that led to MicroStrategy’s 10x stock explosion. But here’s the twist: GameStop brings more than just Bitcoin exposure — it brings meme momentum. Unlike MicroStrategy, which had to win over the market, GME already has an army of loyal retail traders, massive online visibility, and a cultural legacy as the original meme stock. If MicroStrategy was the corporate face of Bitcoin adoption, GameStop is the internet’s version — louder, faster, and potentially more explosive. Yes, the stock dipped on the announcement — typical for big moves like this — but long-term, the upside is undeniable. Bitcoin on the balance sheet gives GME new life, and volatility is GameStop’s comfort zone. With Bitcoin becoming a political and financial flashpoint — highlighted by major figures like JD Vance and Donald Trump Jr. attending the 2025 Bitcoin conference — GME’s move couldn’t be more timely. This is more than a pivot. It’s a power play. GameStop is no longer just a nostalgia-fueled retailer — it’s a digital asset powerhouse in the making. If you missed MicroStrategy’s rise, GameStop might just be your second chance — with even more firepower behind it. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:GMELong
by TopgOptions